In the News

Bots Boost Liver Cancer Outcome

Liver cancer, primarily hepatocellular carcinoma (HCC), is the third most common contributor to cancer-related deaths worldwide. Early-stage HCC has a better prognosis than advanced-stage HCC and can be treated with minimally invasive surgery, including robotic-assisted and laparoscopic options. However, few studies have examined the presumably unique and discrepant short-term and long-term outcomes of robotic-assisted and laparoscopic surgeries. Read more.

Study finds breast cancer recurrence score has different implications for men

The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test. The study indicated that chemotherapy after surgery provided little advantage in overall survival for these women, so they could forgo the treatment.